Ascendis Pharma A/S (Nasdaq: ASND) today announced two oral presentations at ENDO 2025, the annual meeting of the Endocrine ...

Consultants downplayed previous warnings given to the Central Energy Fund about the purchase of Sapref’s oil refinery in South Durban, which has serious implications for the state and the public.